JPS5925311A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JPS5925311A JPS5925311A JP13279882A JP13279882A JPS5925311A JP S5925311 A JPS5925311 A JP S5925311A JP 13279882 A JP13279882 A JP 13279882A JP 13279882 A JP13279882 A JP 13279882A JP S5925311 A JPS5925311 A JP S5925311A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- chondroitin sulfate
- comparative example
- hyaluronic acid
- cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は、グリコサミノグリカンと、エストロゲ/とを
配合することにより皮膚にうるおいを与え、皮1i+7
の生理機能を向上させて皮膚の柔軟性、・弾JJ性及び
表面状態を著るしく改善する化粧料に関するものである
。DETAILED DESCRIPTION OF THE INVENTION The present invention provides moisture to the skin by blending glycosaminoglycan and estrogen,
The present invention relates to cosmetics that significantly improve the flexibility, elasticity, and surface condition of the skin by improving the physiological functions of the skin.
皮1+If医学的見地からみた場合、皮膚の老化現象は
、皮膚中のグリコサミノグリカンの減少に起因すると考
えられている。その結果、皮膚組織は柔−1ツ;性、弾
力性を失い、皮膚のシワが増大し、皮膚9[観的におと
ろえをみせる。グリコサミノグリカン、とくにそのうち
の一つであるヒアルロン酸は、士ル水効ll!:を有し
ているので、皮膚保湿の機構を考察するにあたっても極
めて重要な因子であるくフレグランスジャーナル(FR
AGRAN(I JOURN/lL )第14号第43
〜54頁1975年)。Skin 1+If From a medical point of view, the phenomenon of skin aging is believed to be due to a decrease in glycosaminoglycans in the skin. As a result, the skin tissue loses its softness and elasticity, the wrinkles of the skin increase, and the skin 9 [visually deteriorates]. Glycosaminoglycans, especially one of them, hyaluronic acid, are extremely effective! : Therefore, it is an extremely important factor when considering the mechanism of skin moisturization. Fragrance Journal (FR)
AGRAN (I JOURN/lL) No. 14 No. 43
~54 pages 1975).
皮膚の老化現象を防止するために・あるいは若返りを計
るためにグリコサミノグリカン、例えばコンドロイチン
硫酸、ヒアルロン酸、ムコイチン硫酸、カロニン硫酸、
又はその塩類等を配合した化粧料(特公昭33−500
号公報)、あるいはヒアルロン酸およびその塩類を含有
せしめることにより、皮膚上に皮膚を保護する膜を形成
し、皮1Mをなめらかとなし、皮膚に適度の潤いとはり
をりえる乳化組成物(特開昭55−160712号公報
)等、のするものであり、皮膚上の成分は洗顔や汗など
により簡琳に洗い流されてしまうことを考えると、必ら
ずしも十分な老化防止効果を発揮するとは言い難いもの
である。Glycosaminoglycans, such as chondroitin sulfate, hyaluronic acid, mucoitin sulfate, caronine sulfate, to prevent skin aging or to rejuvenate the skin.
or cosmetics containing its salts (Special Publication No. 33-500)
Or an emulsified composition (especially) that contains hyaluronic acid and its salts to form a protective film on the skin, make the skin smooth, and provide appropriate moisture and firmness to the skin. Considering that the ingredients on the skin are easily washed away by face washing and sweat, they do not necessarily have sufficient anti-aging effects. It is difficult to say that it will.
かかる状況にかんがみ、本発明者らは、rliに皮す
膚に不足しているグリコサミノグリカンを外面的に与え
るだけでなく皮膚の内部に働らきかけるな11ボルモン
と同時にり・えたならばより効果的ではtzいがと考え
、各種試作、試験を行った結果、グリ′−1サミノグリ
カンと父性ホルモンを配合した化il科はそれぞれを単
独に配合した化粧料に比べて、m lr的な効果を有す
ることを見い出し、本発明を完成するに至−)たのであ
る。In view of this situation, the present inventors proposed that it would be possible to not only provide RLI externally with glycosaminoglycans that are lacking in the skin, but also to simultaneously add 11-bolone that acts on the inside of the skin. We thought that it would be more effective, and as a result of making various prototypes and testing, we found that a cosmetic that contains glyc'-1 saminoglycan and paternal hormone has a higher mlr-like effect than a cosmetic that contains each of them alone. They discovered that this method has an effect, and completed the present invention.
1!IIち、イぐ発明はグリコサミノグリカンと女性ホ
ルモ/であるエストロゲ8樽ト配合することを特徴とす
る化粧料を提供するものである◇
つまり、本発明らは皮膚上へ途布することにより速効性
を発揮するグリコサミノグリカンと皮膚組織中の真皮結
合組織に働らきかけ、ヒアルロン接菌な補給と皮LM内
部からのヒアルロン酸の補給をIllっだものであるが
、効果テストを行った結果、栄に相和的な効果でなく相
乗的な効果が得られることを見い出して、本発明に至っ
たのである。1! II. The present invention provides a cosmetic product characterized by a combination of glycosaminoglycan and estrogen, which is a female hormone. It acts on glycosaminoglycans that exhibit fast-acting effects and the dermal connective tissue in the skin tissue, and provides hyaluronic inoculation replenishment and hyaluronic acid replenishment from within the skin's LM, but its effectiveness has been tested. As a result, they discovered that Sakae has a synergistic rather than a mutualistic effect, leading to the present invention.
(以下余白) 以下、本発明の構成について詳述する。(Margin below) Hereinafter, the configuration of the present invention will be explained in detail.
本発明で用いるグリコサミノグリカンは、例えばヒアル
ロン酸、コンドロイチン硫ll!l′A1コンドロイチ
ン硫酸B1コンドロイチン硫酸C1キチン等またはその
塩類であり、これらのうちから一種又は二種以上が任意
に選択される。Glycosaminoglycans used in the present invention include, for example, hyaluronic acid, chondroitin sulfate! l'A1 chondroitin sulfate B1 chondroitin sulfate C1 chitin, etc., or salts thereof, and one or more types are arbitrarily selected from these.
グリコサミノグリカンの塩を形成する塩基としニン等の
塩基性アミノ酸等を例示することができるO
グリコサミノグリカン及び/又はその塩の配合量は該化
粧料に対して005重N%以上が好ましい。Examples include basic amino acids such as nin as a base for forming glycosaminoglycan salts. preferable.
本発明で用いるエストロゲンは、例えばエチニルエスト
ラジオール、〕〕7β−エストラジA−ルエストロン、
ニストリA−ル、ジエチルスチルベストロール、ヘキセ
ストロール等であり、こねらのうちから一種又は二種以
上が任意に選ばれ使用される。Estrogens used in the present invention include, for example, ethinyl estradiol, 7β-estradiA-luestrone,
These include Nistral, diethylstilbestrol, hexestrol, etc., and one or more of them are arbitrarily selected and used.
配合11[は0.0001重量%以上が好ましい。Blend 11 [is preferably 0.0001% by weight or more.
以下、実施例により本発明及び本発明の効果に−)いて
1!工・述する。本発明はこれにより限定されるもので
はない。Hereinafter, the present invention and the effects of the present invention will be explained with reference to Examples. Engineering and description. The present invention is not limited thereby.
(以下余白)
実施例14 比較例1.2 モイスチュアクリーム(
製 法)
Aの油相部、お上びBの水相部をそれぞれ70°Cに加
熱し完全溶解したのち、油相部を水相部中に1111記
実施例1.比較例1.2のモイスチュアクリームを女性
パイ、ル刃名に使用させた。(Left below) Example 14 Comparative example 1.2 Moisture cream (
Manufacturing method) The oil phase of A and the aqueous phase of B are heated to 70°C and completely dissolved, and then the oil phase is added to the aqueous phase in Example 1 of 1111. The moisture cream of Comparative Example 1.2 was used on a woman's pie, Le Haname.
01υI lit 昭和57年1月10日〜57年2
り]0日0 使用方法:顔左右半々に実施例1と比較例
1を10名(lグループ)、実施例1と比較例2を10
名(IIlグループ、比較例1と比較例2を〕0名ずつ
(■グループ)、1日lh回塗布した。01υI lit January 10, 1980 - 2, 1982
] 0 days 0 How to use: Apply Example 1 and Comparative Example 1 to 10 people (l group), and apply Example 1 and Comparative Example 2 to 10 people on both sides of the face.
(Group II, Comparative Example 1 and Comparative Example 2) 0 people each (Group ■) applied the solution 1h times a day.
0 評価項目
1ケ月後の肌のしなやかさ、皮膚のはりを官能テストで
パネルに自己申告させて判定した。結果を表2に示す。0 Evaluation Items Skin suppleness and skin firmness after one month were evaluated by having the panel self-report in a sensory test. The results are shown in Table 2.
(以下余白)
表2(j@
次に実施例1、比較例1の皮膚改善効果を皮膚のコンダ
クタンスを測定することにより評価した。(The following is a margin) Table 2 (j@ Next, the skin improvement effects of Example 1 and Comparative Example 1 were evaluated by measuring skin conductance.
jj法:高周波インピーダンスメーター(アイビイニス
株式会社製)をもちいて皮膚の保水状態をコンダクタン
ス値の測定により評価した。実施例1と比較例1を毎日
−回2週間塗布し、塗布前ト後でd(!l 定したコン
ダクタンス値のa (10人で測定し平均値で表わした
)を表3に示す。数値が大きい程、皮膚の状態が改善さ
れたことを示す。jj method: The water retention state of the skin was evaluated by measuring the conductance value using a high frequency impedance meter (manufactured by Ibinis Co., Ltd.). Example 1 and Comparative Example 1 were applied once every day for two weeks, and the determined conductance values (a (measured by 10 people and expressed as an average value) before and after application) are shown in Table 3. Numerical values The larger the value, the better the skin condition.
表3に示した様に実施例1では塗布前に比べ皮フの保水
状態が著しく向上しているのに対し比較例1においては
、はとんどその効果はみられなかった。As shown in Table 3, in Example 1, the water retention state of the skin was significantly improved compared to before application, whereas in Comparative Example 1, no such effect was observed.
表3 (塗布後の皮膚のコンダクタンス)−、−(塗
布前の皮膚のコンダクタンス)次いで実施例1と比較例
1の皮膚表面状態の改善効果を観察した。Table 3 (Skin conductance after application) -, - (Skin conductance before application) Next, the effect of improving the skin surface condition of Example 1 and Comparative Example 1 was observed.
方法:皮膚の表面形態をレプリカ法(特開昭54−56
280号公報)により観察した。Method: Replica method of skin surface morphology (Japanese Patent Application Laid-open No. 54-56
No. 280).
実施例1と比較例1を毎日−回2週間塗布し、塗布前と
塗布後の皮膚のレプリカを取り、顕微鏡写真にて撮影し
・比較観察した。Example 1 and Comparative Example 1 were applied once every day for two weeks, and replicas of the skin before and after application were taken, micrographs were taken, and comparative observations were made.
結果を図1に示す。Aは使用前の一女性の左頬部の皮膚
表面状態であり・Bは同じ女性の右頬部のものである。The results are shown in Figure 1. A shows the skin surface condition of the left cheek of a woman before use, and B shows the skin surface condition of the same woman's right cheek.
Cは実施例1のクリームを使用した後の左頬部の表面状
態で・Dは比較例1を使用した後の右の頬部のものであ
る・
これらから明らかな通り、使用前は両者はぼ同様の皮膚
形態であるが、2週間後の状態を観察すると実施例1で
は明らかに皮丘皮溝が明確になり本発明品はいちじるし
い改善効果があるという結果を得た。C is the surface condition of the left cheek after using the cream of Example 1.D is the surface condition of the right cheek after using Comparative Example 1.As is clear from these, before use, both were Although the skin morphology was similar, when the condition was observed after 2 weeks, the condyles and grooves were clearly defined in Example 1, indicating that the product of the present invention had a remarkable improvement effect.
一方比較例1では皮丘、皮溝が明確にならず改善効果は
ほとんど見られない。On the other hand, in Comparative Example 1, the skin ridges and skin grooves were not clearly defined and almost no improvement effect was observed.
実施例2 栄養乳液
(製法)
への油相部、およびBの゛水相部をそれぞれ70’に加
熱し完全溶解したのち、油相部を水相部中に混合し、乳
化機にて乳化する。乳化物を熱交換器にて終l晶m′C
まで冷却したのち充填を行った。Example 2 Nutritional emulsion (manufacturing method) After heating the oil phase to the nutritional emulsion (manufacturing method) and the aqueous phase of B to completely dissolve them, the oil phase was mixed into the aqueous phase and emulsified using an emulsifier. do. The emulsion is subjected to final crystallization m'C in a heat exchanger.
After cooling to a certain temperature, filling was performed.
クリームの実施例1と同様な効果があった。The same effect as in Example 1 of the cream was obtained.
実施例3 スキンローション
(IIZ)
(製 法)
A部、およびB部をそれぞれ室温にて攪拌完全溶解した
のち・B部にA部を混合して可溶化し、濾過機にて濾過
した。Example 3 Skin lotion (IIZ) (Manufacturing method) Parts A and B were stirred and completely dissolved at room temperature, and then part A was mixed with part B to solubilize it, and the mixture was filtered using a filter.
実施例1と同様な効果があった00 had the same effect as Example 1
図1(写真)は生物(人)の形態(皮膚表面状態)を示
す。
A:塗布前の左頬部
B;塗布前の右頬部
c:’JNMM例1のモイスチュアクリーム使用後の左
頬部
D=比較例1のモイスチュアクリーム使用後の右頬部
特許出願人 株式会社 資 生堂
1Figure 1 (photo) shows the morphology (skin surface condition) of an organism (human). A: Left cheek area before application B; Right cheek area before application c: 'Left cheek area after using the moisture cream of JNMM Example 1 D = Right cheek area after using the moisture cream of Comparative Example 1 Patent applicant Co., Ltd. Shiseido 1
Claims (1)
とを特徴とする化粧料。A cosmetic characterized by containing glycosaminoglycan and estrogen.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13279882A JPS5925311A (en) | 1982-07-29 | 1982-07-29 | Cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13279882A JPS5925311A (en) | 1982-07-29 | 1982-07-29 | Cosmetic |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5925311A true JPS5925311A (en) | 1984-02-09 |
JPH0420883B2 JPH0420883B2 (en) | 1992-04-07 |
Family
ID=15089808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13279882A Granted JPS5925311A (en) | 1982-07-29 | 1982-07-29 | Cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5925311A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6440412A (en) * | 1987-08-06 | 1989-02-10 | Pola Chem Ind Inc | Cosmetic |
US5767106A (en) * | 1992-02-21 | 1998-06-16 | Hyal Pharmaceutical Corporation | Treatment of disease and conditions associated with macrophage infiltration |
US5824658A (en) * | 1990-09-18 | 1998-10-20 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
US5910489A (en) * | 1990-09-18 | 1999-06-08 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
US5977088A (en) * | 1991-07-03 | 1999-11-02 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US5990096A (en) * | 1990-09-18 | 1999-11-23 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US6140312A (en) * | 1992-02-20 | 2000-10-31 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US6218373B1 (en) | 1992-02-20 | 2001-04-17 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
WO2006004759A3 (en) * | 2004-06-29 | 2006-03-16 | Stephanie N Mcclellan | Topical compositions for anti-aging |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5064442A (en) * | 1973-10-06 | 1975-05-31 |
-
1982
- 1982-07-29 JP JP13279882A patent/JPS5925311A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5064442A (en) * | 1973-10-06 | 1975-05-31 |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6440412A (en) * | 1987-08-06 | 1989-02-10 | Pola Chem Ind Inc | Cosmetic |
US5824658A (en) * | 1990-09-18 | 1998-10-20 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
US5910489A (en) * | 1990-09-18 | 1999-06-08 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
US5962433A (en) * | 1990-09-18 | 1999-10-05 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
US5990096A (en) * | 1990-09-18 | 1999-11-23 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US5977088A (en) * | 1991-07-03 | 1999-11-02 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US6140312A (en) * | 1992-02-20 | 2000-10-31 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US6218373B1 (en) | 1992-02-20 | 2001-04-17 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US5767106A (en) * | 1992-02-21 | 1998-06-16 | Hyal Pharmaceutical Corporation | Treatment of disease and conditions associated with macrophage infiltration |
WO2006004759A3 (en) * | 2004-06-29 | 2006-03-16 | Stephanie N Mcclellan | Topical compositions for anti-aging |
US8039012B2 (en) | 2004-06-29 | 2011-10-18 | McKA, LLC | Topical compositions for anti-aging and methods of using same |
Also Published As
Publication number | Publication date |
---|---|
JPH0420883B2 (en) | 1992-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7083090B2 (en) | Pore-specific beauty essence with EVERYCO extract added and its preparation method | |
JP2832119B2 (en) | Cosmetics | |
CN109602648A (en) | A kind of composition and its preparation method and application with reparation and senile-resistant efficacy | |
CN110123721B (en) | Shampoo composition for improving oily scalp | |
CN107468582A (en) | One kind is compacted anti-wrinkle eye shadow and preparation method thereof | |
CN113768809B (en) | Composition with mild exfoliating effect and preparation method and application thereof | |
JPS5925311A (en) | Cosmetic | |
JPS61180705A (en) | Cosmetic | |
CN106727132A (en) | A kind of gentle moisturizing mildy wash and preparation method thereof | |
JP2005330285A (en) | Skin moisturizing cosmetic composition | |
CN102188359B (en) | Application of leech to nursing of hair or scalp of head, composition and preparation method | |
CN110074996A (en) | A kind of moisture saver mask and preparation method thereof with liquid crystal structure | |
JPS60116618A (en) | Cosmetic | |
CN106074305B (en) | A kind of Noni fruit toothpaste and preparation method thereof with oral mucosa protective effect | |
JP2532495B2 (en) | Skin cosmetics | |
JP3104938B2 (en) | Cosmetics | |
JP2008169196A (en) | External preparation for skin | |
JPS617208A (en) | Pack and peel preparation containing plant powder | |
JPH0466843B2 (en) | ||
JP2015127319A (en) | Skin external preparation | |
JP2002275027A (en) | Cosmetic and cosmetic impregnated in nonwoven fabric | |
JPS62209009A (en) | Cosmetic | |
JP5154283B2 (en) | Topical skin preparation | |
CN114146005B (en) | Stick-shaped skin care product for moisturizing and preparation method thereof | |
JPS6078910A (en) | Skin cosmetic |